ATYR aTYR PHARMA INC
Nasdaq · SEC CIK 1339970 · EDGAR
- Bought, last 12 months
- $962.3K 2 purchases by 1 insiders
- Sold, last 12 months
- $6,293 3 sales by 3 insiders
- Filings on record
- 85 since 2021-09-22, latest 2026-05-28 16:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SCHIMMEL PAUL | Dir | $962.3K | — |
| Shukla Sanjay | Pres, CEO, Dir | — | $3,670 |
| Broadfoot Jill Marie | CFO | — | $1,527 |
| DENYES NANCY | GC | — | $1,096 |
Transactions 47
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-28 16:12 | 2026-05-27 | ATYR | SCHIMMEL PAUL | Dir | P - Purchase | $0.4963 | +100.0K | 779.1K | +15% | +$49.6K |
| D | 2026-02-04 | 2026-02-04 | ATYR | Shukla Sanjay | Pres, CEO, Dir | S - Sale+OE | $0.98 | -3,745 | 153.6K | -2% | -$3,670 |
| D | 2026-02-04 | 2026-02-03 | ATYR | Shukla Sanjay | Pres, CEO, Dir | M - OptEx | — | +10.4K | 157.3K | +7% | — |
| D | 2026-02-04 | 2026-02-03 | ATYR | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 38.9K | +11% | — |
| D | 2026-02-04 | 2026-02-04 | ATYR | Broadfoot Jill Marie | CFO | S - Sale+OE | $0.98 | -1,558 | 37.3K | -4% | -$1,527 |
| D | 2026-02-04 | 2026-02-03 | ATYR | DENYES NANCY | GC | M - OptEx | — | +2,687 | 34.2K | +9% | — |
| D | 2026-02-04 | 2026-02-04 | ATYR | DENYES NANCY | GC | S - Sale+OE | $0.98 | -1,118 | 33.1K | -3% | -$1,096 |
| MI | 2025-10-09 | 2025-10-08+ | ATYR | SCHIMMEL PAUL | Dir | P - Purchase | $0.9127 | +1.00M | 1.41M | +242% | +$912.7K |
| 2025-03-17 | 2025-03-17 | ATYR | Gross Jane A | Dir | P - Purchase | $4.00 | +3,750 | 9,750 | +62% | +$15.0K | |
| D | 2025-02-04 | 2025-02-03 | ATYR | Shukla Sanjay | Pres, CEO, Dir | M - OptEx | — | +10.4K | 146.9K | +8% | — |
| D | 2025-02-04 | 2025-02-03 | ATYR | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 33.0K | +13% | — |
| D | 2025-02-04 | 2025-02-04 | ATYR | Broadfoot Jill Marie | CFO | S - Sale+OE | $3.78 | -1,254 | 31.8K | -4% | -$4,740 |
| D | 2025-02-04 | 2025-02-03 | ATYR | DENYES NANCY | GC | M - OptEx | — | +2,687 | 27.5K | +11% | — |
| D | 2025-02-04 | 2025-02-04 | ATYR | DENYES NANCY | GC | S - Sale+OE | $3.78 | -899 | 26.6K | -3% | -$3,398 |
| MI | 2024-07-24 | 2024-07-22+ | ATYR | SCHIMMEL PAUL | Dir | P - Purchase | $1.84 | +100.0K | 413.0K | +32% | +$184.5K |
| 2024-06-06 | 2024-06-05 | ATYR | DENYES NANCY | GC | P - Purchase | $1.86 | +5,000 | 22.3K | +29% | +$9,300 | |
| 2024-06-03 | 2024-05-31 | ATYR | Broadfoot Jill Marie | CFO | P - Purchase | $1.79 | +5,000 | 28.0K | +22% | +$8,950 | |
| I | 2024-06-03 | 2024-05-30 | ATYR | COUGHLIN TIMOTHY | Dir | P - Purchase | $1.75 | +50.0K | 56.0K | +833% | +$87.5K |
| 2024-06-03 | 2024-05-31 | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $1.81 | +20.0K | 136.5K | +17% | +$36.2K | |
| D | 2024-02-06 | 2024-02-05 | ATYR | Shukla Sanjay | Pres, CEO, Dir | M - OptEx | — | +10.4K | 116.5K | +10% | — |
| D | 2024-02-06 | 2024-02-05 | ATYR | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 22.4K | +20% | — |
| D | 2024-02-06 | 2024-02-06 | ATYR | Broadfoot Jill Marie | CFO | S - Sale+OE | $1.69 | -1,590 | 20.8K | -7% | -$2,687 |
| D | 2024-02-06 | 2024-02-05 | ATYR | DENYES NANCY | GC | M - OptEx | — | +2,688 | 14.8K | +22% | — |
| M | 2023-12-12 | 2023-12-11+ | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $1.18 | +15.0K | 94.2K | +19% | +$17.7K |
| M | 2023-11-13 | 2023-11-10+ | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $1.11 | +15.0K | 91.2K | +20% | +$16.7K |
| 2023-08-01 | 2023-07-28 | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $2.01 | +15.0K | 76.2K | +25% | +$30.1K | |
| DI | 2023-05-19 | 2023-05-17 | ATYR | COUGHLIN TIMOTHY | Dir | G - Gift | $0.00 | +6,000 | 6,000 | New | $0 |
| D | 2023-05-19 | 2023-05-17 | ATYR | COUGHLIN TIMOTHY | Dir | G - Gift | $0.00 | -6,000 | 0 | -100% | $0 |
| I | 2023-05-11 | 2023-05-10 | ATYR | SCHIMMEL PAUL | Dir | P - Purchase | $2.25 | +200.0K | 313.0K | +177% | +$450.0K |
| D | 2023-04-28 | 2023-04-26 | ATYR | COUGHLIN TIMOTHY | Dir | M - OptEx | — | +6,000 | 6,000 | New | — |
| D | 2023-04-28 | 2023-04-26 | ATYR | Zaknoen Sara | Dir | M - OptEx | — | +6,000 | 6,000 | New | — |
| D | 2023-04-28 | 2023-04-26 | ATYR | SCHIMMEL PAUL | Dir | M - OptEx | — | +6,000 | 8,890 | +208% | — |
| D | 2023-04-28 | 2023-04-26 | ATYR | Gross Jane A | Dir | M - OptEx | — | +6,000 | 6,000 | New | — |
| D | 2023-04-28 | 2023-04-26 | ATYR | CLARKE JOHN K | Dir | M - OptEx | — | +6,000 | 19.8K | +43% | — |
| D | 2023-04-28 | 2023-04-26 | ATYR | Lucas Svetlana | Dir | M - OptEx | — | +6,000 | 6,000 | New | — |
| D | 2023-02-06 | 2023-02-03 | ATYR | DENYES NANCY | GC | M - OptEx | — | +2,688 | 7,079 | +61% | — |
| D | 2023-02-06 | 2023-02-03 | ATYR | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 17.0K | +28% | — |
| D | 2023-02-06 | 2023-02-06 | ATYR | Broadfoot Jill Marie | CFO | S - Sale+OE | $2.36 | -1,566 | 15.5K | -9% | -$3,696 |
| D | 2023-02-06 | 2023-02-03 | ATYR | Shukla Sanjay | Pres, CEO, Dir | M - OptEx | — | +10.4K | 61.2K | +20% | — |
| 2022-11-21 | 2022-11-21 | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $2.14 | +10.0K | 50.8K | +25% | +$21.4K | |
| 2022-07-06 | 2022-07-01 | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $2.88 | +15.0K | 40.8K | +58% | +$43.2K | |
| 2022-01-18 | 2022-01-13 | ATYR | Broadfoot Jill Marie | CFO | P - Purchase | $6.75 | +1,923 | 12.1K | +19% | +$13.0K | |
| 2022-01-10 | 2022-01-07 | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $6.76 | +5,000 | 25.8K | +24% | +$33.8K | |
| 2021-11-15 | 2021-11-15 | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $8.58 | +2,500 | 20.8K | +14% | +$21.4K | |
| 2021-09-22 | 2021-09-20 | ATYR | SCHIMMEL PAUL | Dir | G - Gift | $0.00 | -250.0K | 2,890 | -99% | $0 | |
| 2021-09-22 | 2021-09-20 | ATYR | SCHIMMEL PAUL | Dir | P - Purchase | $8.00 | +250.0K | 252.9K | +8,651% | +$2.00M | |
| I | 2021-09-22 | 2021-09-20 | ATYR | SCHIMMEL PAUL | Dir | G - Gift | $0.00 | +250.0K | 679.1K | +58% | $0 |
Purchase Sale Sale after option exercise All abbreviations